Keystone Investors PTE Ltd. Acquires New Shares in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Keystone Investors PTE Ltd. purchased a new position in Intuitive Surgical, Inc. (NASDAQ:ISRG) in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 25,065 shares of the medical equipment provider’s stock, valued at approximately $13,083,000. Intuitive Surgical accounts for 0.9% of Keystone Investors PTE Ltd.’s investment portfolio, making the stock its 21st biggest position.

Several other hedge funds have also recently modified their holdings of the stock. Atala Financial Inc bought a new stake in shares of Intuitive Surgical during the 4th quarter worth approximately $25,000. Berbice Capital Management LLC purchased a new stake in shares of Intuitive Surgical in the 4th quarter valued at $26,000. BankPlus Trust Department acquired a new position in shares of Intuitive Surgical in the 4th quarter valued at $28,000. Kohmann Bosshard Financial Services LLC acquired a new stake in Intuitive Surgical in the fourth quarter valued at approximately $31,000. Finally, Decker Retirement Planning Inc. purchased a new stake in Intuitive Surgical during the 4th quarter worth approximately $36,000. Hedge funds and other institutional investors own 83.64% of the company’s stock.

Analyst Ratings Changes

Several research firms have issued reports on ISRG. Barclays raised their target price on Intuitive Surgical from $610.00 to $674.00 in a research note on Monday, January 27th. Erste Group Bank cut shares of Intuitive Surgical from a “strong-buy” rating to a “hold” rating in a report on Monday, March 17th. Raymond James lifted their price objective on shares of Intuitive Surgical from $560.00 to $688.00 and gave the company an “outperform” rating in a research note on Friday, January 24th. Truist Financial dropped their target price on Intuitive Surgical from $666.00 to $605.00 and set a “buy” rating on the stock in a research report on Monday, March 17th. Finally, UBS Group lifted their price target on Intuitive Surgical from $500.00 to $560.00 and gave the stock a “neutral” rating in a research note on Monday, January 27th. One investment analyst has rated the stock with a sell rating, five have assigned a hold rating and fifteen have given a buy rating to the company’s stock. According to data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average target price of $611.86.

Insider Buying and Selling

In other Intuitive Surgical news, EVP Robert Desantis sold 11,545 shares of Intuitive Surgical stock in a transaction dated Thursday, March 13th. The stock was sold at an average price of $499.22, for a total transaction of $5,763,494.90. Following the completion of the sale, the executive vice president now owns 5,224 shares of the company’s stock, valued at approximately $2,607,925.28. The trade was a 68.85 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, EVP Brian Edward Miller sold 8,900 shares of the stock in a transaction on Tuesday, March 11th. The stock was sold at an average price of $485.07, for a total transaction of $4,317,123.00. Following the sale, the executive vice president now directly owns 5,758 shares in the company, valued at $2,793,033.06. This trade represents a 60.72 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last quarter, insiders sold 33,754 shares of company stock worth $17,691,621. Corporate insiders own 0.90% of the company’s stock.

Intuitive Surgical Price Performance

Shares of NASDAQ ISRG opened at $508.58 on Tuesday. The firm has a 50-day moving average of $561.62 and a 200 day moving average of $532.25. Intuitive Surgical, Inc. has a 1 year low of $364.17 and a 1 year high of $616.00. The stock has a market cap of $181.15 billion, a P/E ratio of 79.34, a price-to-earnings-growth ratio of 5.85 and a beta of 1.43.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.